As one of the frequent complications leading to poor prognosis in hospitalized COVID-19
patients, a better understanding of venous thromboembolism (VTE) in COVID-19 patients is …

Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) may contribute to venous thromboembolism (VTE) with …

Venous thromboembolism (VTE) and major bleeding (MB) are life-threatening complications
described in COVID-19 hospitalized patients and they can be considered as two sides of the …

Despite thromboprophylaxis, patients with coronavirus disease 2019 (COVID‐19) exhibit
hypercoagulability and higher venous thromboembolic risk, although its real incidence is still …

Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized
COVID-19 patients, in particular in patients admitted to the intensive care unit (ICU). In …

Background: Coagulation disorders are frequently encountered among patients infected
with coronavirus disease 2019 (COVID-19), especially among admitted patients with more …

Venous thromboembolism is prevalent in hospitalized COVID-19 patients. Through
systematic review and meta-analysis, we have investigated the differences in clinical …

Previous studies have suggested that COVID-19 pneumonia is associated with an increased
risk of venous thromboembolism (VTE). This study aimed to investigate the incidence of VTE …

Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …